Mancillas-Adame L, Morales-González G

Language: Spanish
References: 7
Page: 91-95
PDF size: 430.52 Kb.

ABSTRACT

The pharmacological treatment of obesity is just one of the therapeutic weapons that the multidisciplinary team involved in the treatment of the obese patients must use, it is helpful in order to acheive better adherence to nutritional and lifestyle modifications. The indications and agents used in the treatment of the obese patients are reviewed.

REFERENCES

1. Thearle M, Aronne LJ. Obesity and phramacologic therapy. Endocrinol Metab Clin 2003; 32:

2. Glazer G. Long-term pharmacotherapy of obesity 2000. Ach Inern Med 2001; 161: 1814-1824.

3. McTigue KM, Harris R, Hemphill B, Lux L, Sutton S, Bunton AJ, Lohr KN. Screening and interventions for obesity in adults: Summary of the evidence for the preventive services task force. Ann Intern Med 2003; 139: 933-949

4. Rivas-Vazquez RA, Rice J, Kalman D. Pharmacotherapy of obesity and eating disorders. Clin Psychopharmacology Update 2003: 34: 562-566.

5. Manson JE, Skerrett PJ, Greenland P, VanItallie TB. The escalating pandemics of obesity and sedentary lifestyle.

6. Dao HH, Frelut ML, Peres G, Bourgeois P, Navarro J. Effects of a multidisciplinary weight loss intervention on anaerobic and aerobic aptitudes in severely obese adolescents. Int J Obes Relat Metab Disord. 2004 Jul;28(7):870-8.

7. Inge TH, Garcia V, Daniels S, Langford L, Kirk S, Roehrig H, Amin R, Zeller M, Higa K. A multidisciplinary approach to the adolescent bariatric surgical patient. J Pediatr Surg. 2004 Mar;39(3):442-7; discussion 446-7.